Elizabeth Kwo - Mar 15, 2022 Form 4 Insider Report for ASENSUS SURGICAL, INC. (ASXC)

Role: Director
Signature: /s/ Joshua Weingard as attorney in fact for Elizabeth Kwo
Stock symbol: ASXC
Transactions as of: Mar 15, 2022
Transactions value $: $9,558
Form type: 4
Date filed: 3/16/2022, 08:00 AM
Previous filing: Nov 19, 2021
Next filing: Jun 15, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ASXC	Common Stock	Purchase	$9.56K	+18K	+33.21%	$0.53	72.2K	Mar 15, 2022	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.53 to $0.5313, with a weighted average price per share of $0.5310. The reporting person undertakes to provide to Asensus Surgical, Inc., any security holder of Asensus Surgical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4.
F2	Includes 54,201 shares underlying restricted stock units that were granted on July 22, 2021, and will vest one-third each on the first, second and third anniversaries of the date of grant as long as the reporting person continues to provide service to Asensus Surgical, Inc.

Content

The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.53 to $0.5313, with a weighted average price per share of $0.5310. The reporting person undertakes to provide to Asensus Surgical, Inc., any security holder of Asensus Surgical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4.

Includes 54,201 shares underlying restricted stock units that were granted on July 22, 2021, and will vest one-third each on the first, second and third anniversaries of the date of grant as long as the reporting person continues to provide service to Asensus Surgical, Inc.